Developing affordable methods for creating modified DNA
Innovations to expand and accelerate the commercial impact of DNA modifications
['FUNDING_OTHER'] · DNALI DATA TECHNOLOGIES, INC. · NIH-10922503
This study is working on a new, eco-friendly way to make special types of DNA that can help scientists better understand health and develop new treatments, which could lead to improved tests and therapies for patients like you.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | DNALI DATA TECHNOLOGIES, INC. (nih funded) |
| Locations | 1 site (CARY, UNITED STATES) |
| Trial ID | NIH-10922503 on ClinicalTrials.gov |
What this research studies
This research focuses on improving the synthesis of chemically modified DNA, which is crucial for understanding biological processes and developing biomedical applications. The team has created a new technology that uses sustainable enzymatic methods to produce modified DNA at a lower cost and under milder conditions compared to traditional methods. By addressing the limitations of current synthesis techniques, the project aims to make a wider variety of DNA modifications accessible for research and clinical use. Patients may benefit from advancements in diagnostics and therapies that rely on these modified DNA products.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals involved in or affected by conditions that require advanced genetic testing or therapies utilizing modified DNA.
Not a fit: Patients who do not require genetic testing or therapies involving DNA modifications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more affordable and accessible DNA modifications, enhancing the development of new diagnostic tools and treatments.
How similar studies have performed: Previous research has shown promise in developing alternative methods for DNA synthesis, indicating potential for success with this innovative approach.
Where this research is happening
CARY, UNITED STATES
- DNALI DATA TECHNOLOGIES, INC. — CARY, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: TOMEK, KYLE — DNALI DATA TECHNOLOGIES, INC.
- Study coordinator: TOMEK, KYLE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.